A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)
PHASE2
At present there is no approved drug treatment for Covid-19. In this study ...
Status
Completed
Location
Military Medical Academy, Clinic of Infectious Diseases